Thermo Fisher Scientific's acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It's Thermo Fisher's biggest acquisition since its 2021 buyout of contract research organization PPD.
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusitalked about the pharma company's work in HIV and hepatitis and how her personal background informed her team's work in developing a Covid-19 treatment.
By Frank Vinluan Tuesday, November 1, 2022 6:00 AM
Human Immunology Bioscience aims to stand apart in autoimmune disease drug research with therapies that address cells at the root of a range of allergic and inflammatory disorders. The biotech has a lead program licensed from MorphoSys in clinical development for two rare kidney diseases and $120 million to support that antibody and other biologic drugs in its pipeline.
By Marissa Plescia Monday, October 31, 2022 5:14 PM
The seed funding was co-led by Felicis Ventures and SemperVirens. Midi Health will use the $14 million to expand beyond California, form new partnerships and train and hire additional staff.
While the top-level view of the growth in the hospice industry at 20-plus percent is impressive, it's worth looking at a few prominent examples to gain further insight into this accelerating trend.
By Marissa Plescia Monday, October 31, 2022 5:01 PM
The value-based partnership is for Humana Medicare Advantage HMO and PPO plan members with chronic kidney disease, who are living in Tennessee, Alabama, Mississippi and Louisiana. These members can access Monogram's specialized care resources, such as in-home primary and specialty care visits, medication management, dialysis and social services.
By Smriti Kirubanandan Monday, October 31, 2022 9:00 AM
People who experience food insecurity also experience health issues such as obesity, diabetes, depression, high levels of stress, anxiety, and long-term consequences due to less access and affordability to nutritious food
No comments